Skip to main content
UniHealth

Doctor search

Jesus Luigi Borrillo, MD

Ophthalmology · Mountain View

NPI 1861487100

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
31
7 carriers
Offices
4

Offices

4 locations · Northern California Retina Vitreous Associates Medical Group, Inc. · 7 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital · Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plans that list them

31 plans · 7 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Borrillo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

31 of 31 plans

Plans whose provider directory lists this clinician
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Blue Shield Inspire (HMO)Blue Shield of CaliforniaListedAug 26, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Peninsula Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.139BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.242BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.27 to 2.15) · 1,258 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.51 to 1.1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths155.44 (112.67 to 198.21) · 90 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 188 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9 · 473 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 342 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 485 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 3,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 6,904 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,052 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.43 to 5.39) · 1,695 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.72 (0.17 to 3.28) · 665 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,545 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.1 (1.3 to 12.9) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.96 (2.63 to 9.29) · 653 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.08) · 418 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.14 (0 to 0.78) · 5,539 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.7 · 192 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.215No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.263No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.74No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 300 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.2 · 207 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.6 · 531 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits24.3 · 343 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 449 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.5 (2.8 to 7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.6 (6.7 to 13.7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11 · 45 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 117 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.2) · 584 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 764 casesNo differentJan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Patient survey stars by topic at Peninsula Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean76%
Nurses "always" communicated well81%
Doctors "always" communicated well80%
Staff "always" explained58%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$1,732,342

Medicare paid this office $1,732,342 for 893 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg198$1,042,219None
Short return visit (20+ min)728$133,036$83
Injection of drug into eye270$132,342$113
Injection, faricimab-svoa, 0.1 mg21$128,688None
Imaging of retina819$96,845$41
See all 13 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg198$1,042,219None
Short return visit (20+ min)728$133,036$83
Injection of drug into eye270$132,342$113
Injection, faricimab-svoa, 0.1 mg21$128,688None
Imaging of retina819$96,845$41
Compounded drug, not otherwise classified89$23,029None
Exam of retinal blood vessels using a special camera after injection of a dye118$19,748$167
Established patient problem focused exam of visual system156$13,742$85
New patient problem focused exam of visual system105$9,214$88
Established patient complete exam of visual system46$6,310$134
Photography of the retina108$5,393$35
New patient complete exam of visual system28$3,848$137
2d ultrasound scan of eye tissue and structures11$469$39

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

893 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 25% · Women 56% · Also on Medicaid 13% · Health risk score 1.41. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 74% · Diabetes 34% · Coronary heart disease 28% · Chronic kidney disease 27% · Atrial fibrillation 19% · Heart failure 17% · Cancer 15% · Depression 13% · COPD 10% · Stroke 9% · Dementia 7%.

The office billed $5,123,576, Medicare allowed $2,217,992 and paid $1,732,342; for 13,152 services of 35 kinds; $1,253,995 of it was for drugs given in the office and $478,346 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202489313,152781.41$5,123,576$1,732,342
20238329,474781.43$4,911,879$1,683,889
20227927,618781.43$5,001,272$1,780,134
20218418,454781.43$5,287,561$2,010,200
20207897,973781.63$4,349,407$1,672,201
20199119,283781.60$4,438,710$1,720,350
20188858,780771.60$3,661,294$1,421,772
20178197,854771.59$2,931,675$1,179,094
20167797,902771.52$2,241,836$1,080,726
20157637,128771.47$1,787,150$882,748
20148126,568771.53$1,461,763$775,107
20138476,904771.54$1,447,648$827,969

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg171$1,114,791None
Short return visit (20+ min)506$116,795$86
Injection of drug into eye247$116,138$105
Imaging of retina752$83,039$38
Injection, ranibizumab, 0.1 mg15$59,047None
Established patient complete exam of visual system374$34,562$90
Compounded drug, not otherwise classified67$20,562None
Exam of retinal blood vessels using a special camera after injection of a dye133$19,197$143
New patient complete exam of visual system122$16,650$136
Established patient problem focused exam of visual system217$15,206$61
Photography of the retina141$6,888$35
New patient problem focused exam of visual system15$1,323$88

2022: 12 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg190$1,238,692None
Injection, ranibizumab, 0.1 mg23$126,918None
Injection of drug into eye272$123,051$104
Imaging of retina743$81,206$37
Established patient complete exam of visual system411$55,999$106
Established patient problem focused exam of visual system339$48,790$81
Compounded drug, not otherwise classified66$20,127None
New patient complete exam of visual system108$14,547$135
Exam of retinal blood vessels using a special camera after injection of a dye73$9,274$127
Photography of the retina78$4,668$35
New patient problem focused exam of visual system11$876$80
2d ultrasound scan of eye tissue and structures11$574$48

2021: 15 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg200$1,342,636None
Injection, ranibizumab, 0.1 mg27$207,048None
Injection of drug into eye284$127,706$109
Established patient problem focused exam of visual system436$87,684$84
Imaging of retina553$50,414$41
Established patient complete exam of visual system389$48,898$103
Photography of the retina580$41,844$36
New patient complete exam of visual system152$20,262$133
Exam of retinal blood vessels using a special camera after injection of a dye124$14,930$120
Compounded drug, not otherwise classified60$13,235None
Destruction of leaking blood vessels of retina using laser11$5,822$342
Short return visit60$3,468$56
Short return visit (20+ min)38$3,322$87
New patient problem focused exam of visual system11$937$85
2d ultrasound scan of eye tissue and structures16$850$47

2020: 13 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg153$987,965None
Injection, ranibizumab, 0.1 mg28$240,087None
Established patient problem focused exam of visual system416$115,620$83
Injection of drug into eye259$94,062$93
Established patient complete exam of visual system430$59,457$106
Photography of the retina624$54,247$43
Imaging of retina305$36,262$40
New patient complete exam of visual system120$15,634$130
Compounded drug, not otherwise classified68$12,772None
Exam of retinal blood vessels using a special camera after injection of a dye99$10,327$103
New patient visit (45+ min)13$2,069$159
New patient problem focused exam of visual system16$1,103$69
2d ultrasound scan of eye tissue and structures11$732$46

2019: 16 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg151$878,526None
Injection, ranibizumab, 0.1 mg45$299,687None
Established patient problem focused exam of visual system482$137,556$81
Injection of drug into eye287$101,735$96
Photography of the retina693$71,869$49
Established patient complete exam of visual system516$70,748$106
Imaging of retina465$43,897$38
New patient complete exam of visual system162$20,962$129
Compounded drug, not otherwise classified99$17,275None
Exam of retinal blood vessels using a special camera after injection of a dye153$14,326$93
Photocoagulation treatment to prevent detachment of retina17$8,993$500
Imaging of optic nerve22$994$33
2d ultrasound scan of eye tissue and structures16$912$48
New patient problem focused exam of visual system12$851$71
Examination of eye by ophthalmoscope with retinal drawing13$611$23
Examination of eye by ophthalmoscope with retinal drawing12$565$27

2018: 16 services

Original Medicare services billed in 2018
Injection, aflibercept, 1 mg106$669,201None
Injection, ranibizumab, 0.1 mg27$194,506None
Established patient problem focused exam of visual system459$137,524$81
Injection of drug into eye295$100,733$94
Established patient complete exam of visual system517$70,747$105
Imaging of retina598$67,369$39
Photography of the retina464$45,473$55
Compounded drug, not otherwise classified173$30,128None
Injection, dexamethasone, intravitreal implant, 0.1 mg11$28,579None
New patient complete exam of visual system145$18,824$130
Exam of retinal blood vessels using a special camera after injection of a dye136$11,758$85
2d ultrasound scan of eye tissue and structures23$2,007$69
Examination of eye by ophthalmoscope with retinal drawing30$1,204$25
New patient problem focused exam of visual system16$1,186$74
Examination of eye by ophthalmoscope with retinal drawing28$1,147$23
Imaging of optic nerve25$723$29

2017: 18 services

Original Medicare services billed in 2017
Injection, aflibercept, 1 mg84$551,405None
Established patient problem focused exam of visual system402$121,987$78
Injection, ranibizumab, 0.1 mg19$98,033None
Injection of drug into eye267$82,414$92
Imaging of retina633$73,522$38
Established patient complete exam of visual system494$67,399$99
Photography of the retina317$31,703$65
Compounded drug, not otherwise classified167$28,189None
New patient complete exam of visual system117$16,441$141
Removal of membrane of retina12$13,028$1,086
Exam of retinal blood vessels using a special camera after injection of a dye157$11,727$74
Destruction of leaking blood vessels of retina using laser17$7,163$326
Photocoagulation treatment to prevent detachment of retina13$6,596$471
New patient visit (45+ min)42$4,996$119
2d ultrasound scan of eye tissue and structures22$2,331$83
Examination of eye by ophthalmoscope with retinal drawing28$1,085$25
Examination of eye by ophthalmoscope with retinal drawing13$478$23
Imaging of optic nerve17$477$28

2016: 16 services

Original Medicare services billed in 2016
Injection, aflibercept, 1 mg72$418,333None
Established patient problem focused exam of visual system398$112,697$75
Injection, ranibizumab, 0.1 mg15$93,644None
Imaging of retina601$80,075$41
Injection of drug into eye281$79,246$94
Established patient complete exam of visual system471$64,318$101
Injection, dexamethasone, intravitreal implant, 0.1 mg14$30,753None
Compounded drug, not otherwise classified190$28,544None
Exam of retinal blood vessels using a special camera after injection of a dye141$26,888$102
Photography of the retina264$23,218$73
New patient visit (45+ min)146$19,436$133
Destruction of leaking blood vessels of retina using laser12$3,720$286
2d ultrasound scan of eye tissue and structures26$2,534$77
Examination of eye by ophthalmoscope with retinal drawing20$833$25
Examination of eye by ophthalmoscope with retinal drawing19$746$22
Imaging of optic nerve14$577$41

2015: 16 services

Original Medicare services billed in 2015
Injection, aflibercept, 1 mg52$288,962None
Established patient problem focused exam of visual system405$111,239$77
Injection, ranibizumab, 0.1 mg19$89,870None
Imaging of retina577$75,330$42
Injection of drug into eye260$70,956$103
Established patient complete exam of visual system450$60,344$104
Exam of retinal blood vessels using a special camera after injection of a dye132$28,455$104
Photography of the retina255$24,147$74
New patient visit (45+ min)146$20,315$139
Unclassified biologics164$19,665None
Destruction of leaking blood vessels of retina using laser11$17,529$974
Compounded Drug, Not Otherwise Classified84$6,003$55
Photocoagulation treatment to prevent detachment of retina11$5,615$468
2d ultrasound scan of eye tissue and structures24$3,374$89
Examination of eye by ophthalmoscope with retinal drawing49$1,883$24
Examination of eye by ophthalmoscope with retinal drawing15$618$26

2014: 14 services

Original Medicare services billed in 2014
Injection, aflibercept, 1 mg41$218,180None
Injection, ranibizumab, 0.1 mg19$99,514None
Established patient problem focused exam of visual system409$94,090$76
Imaging of retina594$68,018$42
Injection of drug into eye233$63,214$96
Established patient complete exam of visual system465$61,798$100
Exam of retinal blood vessels using a special camera after injection of a dye145$29,407$102
Photography of the retina265$25,363$75
Unclassified biologics175$23,155None
New patient visit (45+ min)164$23,116$141
2d ultrasound scan of eye tissue and structures25$2,826$86
Imaging of optic nerve26$1,016$39
Examination of eye by ophthalmoscope with retinal drawing32$761$24
Examination of eye by ophthalmoscope with retinal drawing20$513$26

2013: 15 services

Original Medicare services billed in 2013
Injection, aflibercept, 1 mg44$226,817None
Established patient problem focused exam of visual system438$106,505$78
Injection, ranibizumab, 0.1 mg27$102,409None
Imaging of retina537$65,901$43
Injection of drug into eye242$62,905$92
Established patient complete exam of visual system474$61,496$101
Exam of retinal blood vessels using a special camera after injection of a dye185$39,408$106
Photography of the retina322$28,628$70
New patient visit (45+ min)177$25,604$145
Unclassified biologics176$21,569None
Destruction of leaking blood vessels of retina using laser17$17,907$995
2d ultrasound scan of eye tissue and structures29$4,288$88
Examination of eye by ophthalmoscope with retinal drawing50$1,349$23
Imaging of optic nerve30$1,343$42
Examination of eye by ophthalmoscope with retinal drawing22$542$25

Medicaid work

$137,427 in 2024

Medicaid paid $137,427 for 1,734 billed services this clinician did in 2024, up to 62 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)342$82,908
Short return visit (20+ min)504$21,887
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina720$20,865
Injection, bevacizumab, 10 mg140$7,175
Aflibercept injection14$4,093
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient14$500
Medicaid work by year
20241,734662$137,427
20231,917755$152,827
20221,521549$134,994
20211,501637$247,275
20201,170637$123,590
20191,825538$110,947
20181,934538$106,287
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)410$86,445
Aflibercept injection28$30,475
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina773$18,518
Short return visit (20+ min)488$8,965
Injection, bevacizumab, 10 mg112$3,898
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient69$2,519
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST37$2,005

2022

Largest Medicaid services in 2022
Intravitreal injection of a pharmacologic agent (separate procedure)319$56,122
Aflibercept injection58$46,783
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina765$19,007
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient294$10,320
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST85$2,762

2021

Largest Medicaid services in 2021
Aflibercept injection91$143,647
Intravitreal injection of a pharmacologic agent (separate procedure)284$68,833
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient391$14,780
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT443$14,282
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina279$5,248
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST13$486

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)164$55,289
Aflibercept injection14$32,397
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient443$16,565
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT415$13,766
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina118$4,354
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST16$1,219

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)269$65,704
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient626$17,194
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT534$14,976
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina331$10,942
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST65$2,131

2018

Largest Medicaid services in 2018
Intravitreal injection of a pharmacologic agent (separate procedure)312$64,243
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina625$14,998
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient612$13,518
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT251$8,448
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST134$5,080

Drugs they prescribed that Part D paid

$27,873

Pharmacies billed $27,873 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 2% of their Part D prescriptions (11 of 681) in 2024. A higher opioid share than 9 in 10 peers; the typical ophthalmology clinician is at 0%.

522 generic and 159 brand-name prescriptions · $27,873 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lumigan11$3,209$292
Brimonidine37$2,548$69
Erythromycin183$1,798$10
Prednisolone Acetate38$1,055$28
Travoprost11$997$91
See all 12 drugs
Every Part D drug this clinician prescribed
Lumigan11$3,209$292
Brimonidine37$2,548$69
Erythromycin183$1,798$10
Prednisolone Acetate38$1,055$28
Travoprost11$997$91
Acetazolamide Er17$788$46
Latanoprost70$782$11
Eplerenone19$775$41
Diclofenac62$577$9
Timolol Maleate100$546$5
Neomycin-Polymyxin-Dexameth41$442$11
Dorzolamide15$305$20

Year by year

Part D prescribing by year
20246812192% (11)23%$27,873
2023636197None33%$45,951
20226801783% (20)34%$40,821
20215531595% (28)36%$55,609
20204741303% (13)40%$62,541
20195221594% (22)46%$75,046
20185471605% (26)52%$82,261
20176181646% (39)47%$80,116
20166581738% (50)52%$76,297
20154991435% (24)55%$71,988
20144351236% (24)56%$46,677
20134151187% (29)53%$40,521

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Part D drugs prescribed in 2023
Prolensa25$9,505$380
Lumigan22$5,747$261
Alphagan P12$3,777$315
Brimonidine38$2,505$66
Timolol Maleate107$1,496$14
Erythromycin140$1,473$11
Latanoprost88$1,462$17
Acetazolamide Er16$923$58
Eplerenone15$902$60
Prednisolone Acetate32$852$27
Neomycin-Polymyxin-Dexameth30$455$15
Dorzolamide14$313$22
Ketorolac Tromethamine12$166$14
Diclofenac12$134$11

2022: 15 drugs

Part D drugs prescribed in 2022
Lumigan16$7,535$471
Alphagan P26$5,450$210
Prolensa13$4,448$342
Latanoprost143$2,733$19
Timolol Maleate115$1,959$17
Brimonidine30$1,588$53
Acetazolamide Er15$1,478$99
Eplerenone20$1,435$72
Prednisolone Acetate31$1,119$36
Erythromycin93$965$10
Neomycin-Polymyxin-Dexameth35$568$16
Dorzolamide15$478$32
Dorzolamide-Timolol17$428$25
Ondansetron Odt11$122$11
Acetaminophen-Codeine20$96$5

2021: 17 drugs

Part D drugs prescribed in 2021
Alphagan P19$7,763$409
Lumigan11$6,663$606
Prolensa15$5,384$359
Timolol Maleate86$3,589$42
Loteprednol Etabonate11$3,541$322
Latanoprost77$1,967$26
Prednisolone Acetate31$1,717$55
Brimonidine24$1,203$50
Eplerenone18$1,191$66
Acetazolamide Er12$751$63
Erythromycin49$602$12
Dorzolamide15$557$37
Neomycin-Polymyxin-Dexameth30$459$15
Diclofenac19$198$10
Ondansetron Odt13$197$15
Acetaminophen-Codeine28$167$6
Spironolactone11$20$2

2020: 13 drugs

Part D drugs prescribed in 2020
Alphagan P22$9,238$420
Prolensa13$5,661$435
Timolol Maleate77$4,873$63
Durezol24$4,740$198
Olopatadine41$2,670$65
Latanoprost66$1,949$30
Eplerenone20$1,802$90
Prednisolone Acetate17$1,258$74
Brimonidine16$608$38
Erythromycin28$356$13
Neomycin-Polymyxin-Dexameth18$276$15
Ondansetron Odt11$110$10
Acetaminophen-Codeine13$60$5

2019: 17 drugs

Part D drugs prescribed in 2019
Travatan Z12$8,648$721
Prolensa27$7,925$294
Alphagan P17$6,966$410
Lumigan11$6,218$565
Durezol24$5,010$209
Combigan11$4,328$393
Pazeo14$3,314$237
Lotemax11$2,784$253
Olopatadine26$2,778$107
Prednisolone Acetate33$1,989$60
Timolol Maleate81$1,953$24
Latanoprost58$1,283$22
Eplerenone12$671$56
Neomycin-Polymyxin-Dexameth31$482$16
Erythromycin30$269$9
Ondansetron Odt17$141$8
Acetaminophen-Codeine22$103$5

2018: 16 drugs

Part D drugs prescribed in 2018
Lumigan27$10,036$372
Durezol33$7,026$213
Alphagan P19$6,646$350
Combigan21$6,582$313
Prolensa17$5,457$321
Pazeo12$4,676$390
Olopatadine46$3,803$83
Timolol Maleate72$1,254$17
Prednisolone Acetate30$1,210$40
Latanoprost46$1,174$26
Acetazolamide12$885$74
Neomycin-Polymyxin-Dexameth32$464$15
Ketorolac Tromethamine15$310$21
Erythromycin32$227$7
Ondansetron Odt13$150$12
Acetaminophen-Codeine23$82$4

2017: 19 drugs

Part D drugs prescribed in 2017
Lumigan28$10,982$392
Alphagan P47$10,163$216
Combigan34$8,289$244
Travatan Z13$6,835$526
Restasis11$5,600$509
Prolensa18$5,335$296
Pazeo13$4,440$342
Durezol17$3,713$218
Acetazolamide23$2,323$101
Prednisolone Acetate33$1,825$55
Neomycin-Polymyxin-Dexameth53$789$15
Olopatadine11$764$69
Timolol Maleate83$722$9
Ketorolac Tromethamine16$629$39
Latanoprost27$552$20
Brimonidine13$493$38
Ondansetron Odt14$333$24
Erythromycin23$167$7
Acetaminophen-Codeine35$150$4

2016: 15 drugs

Part D drugs prescribed in 2016
Alphagan P73$14,222$195
Lumigan34$9,303$274
Combigan29$6,156$212
Durezol27$6,030$223
Pataday19$5,142$271
Acetazolamide40$4,611$115
Prolensa13$3,653$281
Lotemax11$2,219$202
Timolol Maleate91$2,126$23
Prednisolone Acetate26$1,590$61
Ketorolac Tromethamine23$1,056$46
Latanoprost47$959$20
Neomycin-Polymyxin-Dexameth56$879$16
Erythromycin21$292$14
Acetaminophen-Codeine46$282$6

2015: 15 drugs

Part D drugs prescribed in 2015
Lumigan37$8,316$225
Pataday30$7,852$262
Alphagan P45$7,230$161
Travatan Z12$6,930$577
Durezol23$6,896$300
Combigan21$5,128$244
Prolensa19$4,584$241
Acetazolamide29$3,697$127
Prednisolone Acetate29$1,694$58
Neomycin-Polymyxin-Dexameth45$848$19
Timolol Maleate54$608$11
Ketorolac Tromethamine13$452$35
Latanoprost16$381$24
Erythromycin15$209$14
Acetaminophen-Codeine23$95$4

2014: 13 drugs

Part D drugs prescribed in 2014
Lumigan49$7,951$162
Travatan Z23$5,870$255
Combigan24$4,486$187
Durezol21$3,769$179
Pataday24$3,657$152
Alphagan P28$3,569$127
Acetazolamide33$3,044$92
Timolol Maleate43$986$23
Neomycin-Polymyxin-Dexameth47$794$17
Prednisolone Acetate15$572$38
Ketorolac Tromethamine13$272$21
Erythromycin12$166$14
Hydrocodone-Acetaminophen12$153$13

2013: 13 drugs

Part D drugs prescribed in 2013
Lumigan47$6,995$149
Combigan31$5,855$189
Travatan Z23$5,500$239
Alphagan P28$3,864$138
Acetazolamide37$2,642$71
Patanol11$2,533$230
Pataday12$2,021$168
Neomycin-Polymyxin-Dexameth39$769$20
Timolol Maleate34$623$18
Ketorolac Tromethamine25$453$18
Latanoprost20$392$20
Prednisolone Acetate11$201$18
Hydrocodone-Acetaminophen29$84$3

Money from drug and device companies

$227 in 2025

Industry payments by year
202534None$227
202445None$225
2023610None$517
202222None$52
202111None$14
202022None$41
2019412None$1,386

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Alcon VisionHydrus Microstent$159
1 payment
  • Meals for Hydrus Microstent · 2025-06-17 · $159
Regeneron Healthcare SolutionsEylea Hd$35
1 payment
  • Meals for Eylea Hd · 2025-08-14 · $35
Genentech USAVabysmo$33
2 payments
  • Meals for Vabysmo · 2025-03-18 · $16
  • Meals for Vabysmo · 2025-03-18 · $17
See all 4 published payments
Every published payment
Regeneron Healthcare SolutionsMeals · 2025-08-14Eylea Hd$35
Alcon VisionMeals · 2025-06-17Hydrus Microstent$159
Genentech USAMeals · 2025-03-18Vabysmo$16
Genentech USAMeals · 2025-03-18Vabysmo$17
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $225

Payments by company in 2024
RxSightRxsight Contact Lens$114
1 payment
  • Meals for Rxsight Contact Lens · 2024-06-12 · $114
Genentech USAVabysmo$63
2 payments
  • Meals for Vabysmo · 2024-10-21 · $34
  • Meals for Vabysmo · 2024-04-23 · $30
Almatica PharmaLoreev Xr$27
1 payment
  • Meals for Loreev Xr · 2024-09-13 · $27
Regeneron Healthcare SolutionsEylea Hd$21
1 payment
  • Meals for Eylea Hd · 2024-04-30 · $21

2023: $517

Payments by company in 2023
Genentech USAVabysmo$243
4 payments
  • Meals · 2023-11-25 · $149
  • Meals for Vabysmo · 2023-10-31 · $35
  • Meals for Vabysmo · 2023-07-25 · $35
  • Meals for Vabysmo · 2023-06-01 · $24
Alcon VisionConstellation$117
2 payments
  • Meals for Constellation · 2023-04-07 · $74
  • Meals for Constellation · 2023-04-06 · $44
Regeneron PharmaceuticalsEylea$74
1 payment
  • Meals for Eylea · 2023-04-03 · $74
Apellis PharmaceuticalsSyfovre$32
1 payment
  • Meals for Syfovre · 2023-03-22 · $32
Regeneron Healthcare SolutionsEylea Hd$30
1 payment
  • Meals for Eylea Hd · 2023-10-23 · $30
Bausch & Lomb AmericasXipere$21
1 payment
  • Meals for Xipere · 2023-08-08 · $21

2022: $52

Payments by company in 2022
Genentech USAVabysmo$27
1 payment
  • Meals for Vabysmo · 2022-10-28 · $27
Alimera SciencesIluvien$25
1 payment
  • Meals for Iluvien · 2022-05-10 · $25

2021: $14

Payments by company in 2021
Bausch & Lomb a division of Bausch Health USLotemax Sm$14
1 payment
  • Meals for Lotemax Sm · 2021-03-08 · $14

2020: $41

Payments by company in 2020
Novartis PharmaceuticalsBeovu$23
1 payment
  • Meals for Beovu · 2020-02-06 · $23
Regeneron Healthcare SolutionsEylea$18
1 payment
  • Meals for Eylea · 2020-09-15 · $18

2019: $1,386

Payments by company in 2019
Novartis PharmaceuticalsBeovu$804
8 payments
  • Meals for Beovu · 2019-11-14 · $111
  • Meals for Beovu · 2019-10-29 · $17
  • Meals for Beovu · 2019-10-16 · $17
  • Travel for Beovu · 2019-07-25 · $210
  • Meals for Beovu · 2019-07-25 · $127
  • Meals for Beovu · 2019-07-24 · $125
  • Meals · 2019-07-18 · $125
  • Meals · 2019-06-13 · $72
AllerganOzurdex$434
2 payments
  • Meals for Ozurdex · 2019-07-30 · $18
  • Education · 2019-07-14 · $417
Alexion PharmaceuticalsSoliris$125
1 payment
  • Meals for Soliris · 2019-08-22 · $125
Genentech USALucentis$22
1 payment
  • Meals for Lucentis · 2019-10-22 · $22

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novartis Pharmaceuticals Corporation · A 64-Week, Phase 3b, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6mg Compared To Aflibercept 2mg in A Treat To Control Regimen in Patients With Neovascular Age-Related Macular Degeneration · 2020Their institution$4,214
Novartis Pharmaceuticals Corporation · A 64-Week, Phase 3b, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6mg Compared To Aflibercept 2mg in A Treat To Control Regimen in Patients With Neovascular Age-Related Macular Degeneration · 2021Their institution$256
Novartis Pharmaceuticals Corporation · A 64-Week, Phase 3b, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6mg Compared To Aflibercept 2mg in A Treat To Control Regimen in Patients With Neovascular Age-Related Macular Degeneration · 2022Their institution$128

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1861487100
Licence
CA 00A78255
Trained
Northwestern University Feinberg Medical School, 1996
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A78255
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
2485 Hospital Dr, Ste 200, Orchard Pavilion, Mountain View, CA, 94040
NPI first listed
2005-09-13
NPI last updated
2013-03-13

This is when the NPI record was last certified, not a medical board exam.